🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to measure the effect and safety of treatment ...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2024-10-30
Trial ID
NCT06433219
Treatments Being Tested
The purpose of Study GS-01-934 was to assess the efficacy and safety of two...
Status
Completed
Location
AIDS Healthcare Foundation Research
Start Date
2003-07
Trial ID
NCT00112047
A study to investigate efficacy and safety of ceralasertib plus durvalumab ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-06-21
Trial ID
NCT05941897
Treatments Being Tested
The ATR (ataxia-telangiectasia and Rad3 related protein) inhibitor BAY18953...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2017-07-06
Trial ID
NCT03188965
Treatments Being Tested
The primary objective of this study is to assess glomerular function before...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-15
Trial ID
NCT02246998
The primary purpose of this study is to define the maximum tolerated dose (...
Status
Completed
Location
#1014, Northwestern University
Start Date
2020-07-22
Trial ID
NCT04497116
Treatments Being Tested
This biomarker study has been designed to assess the effects of different a...
Status
Completed
Location
Research Site
Start Date
2017-09-18
Trial ID
NCT03022409
Treatments Being Tested
The purpose of this research study is to see if the combination of study dr...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2024-11-14
Trial ID
NCT06518564
This is a single sequence 2-period open label study in participants with ad...
Status
Completed
Location
Pharmaceutical Research Associates Magyarország Kutatás - Fejlesztési Kft., Klinikai Farmakológiai Vizsgálóhely
Start Date
2024-03-25
Trial ID
NCT06308263
ATARI trial tests the ATR inhibitor drug ceralasertib (AZD6738) alone and i...
Status
Active Not Recruiting
Location
The Ottawa Hospital Cancer Centre
Start Date
2019-11-27
Trial ID
NCT04065269
Treatments Being Tested